Phys Act Nutr Search

CLOSE


Phys Act Nutr > Volume 24(2); 2020 > Article
Kyun, Yoo, Hashimoto, Tomi, Teramoto, Kim, and Lim: Effects of exogenous lactate administration on fat metabolism and glycogen synthesis factors in rats

Abstract

[Purpose]

Lactate has several beneficial roles as an energy resource and in metabolism. However, studies on the effects of oral administration of lactate on fat metabolism and glycogen synthesis are limited. Therefore, the purpose of the present study was to investigate how oral administration of lactate affects fat metabolism and glycogen synthesis factors at specific times (0, 30, 60, 120 min) after intake.

[Methods]

Male Sprague Dawley (SD) rats (n = 24) were divided into four groups as follows: the control group (0 min) was sacrificed immediately after oral lactate administration; the test groups were administered lactate (2 g/kg) and sacrificed after 30, 60, and 120 min. Skeletal muscle and liver mRNA expression of GLUT4, FAT/CD36, PDH, CS, PC and GYS2 was assessed using reverse transcription-polymerase chain reaction.

[Results]

GLUT4 and FAT/CD36 expression was significantly increased in skeletal muscle 120 min after lactate administration. PDH expression in skeletal muscle was altered at 30 and 120 min after lactate consumption, but was not significantly different compared to the control. CS, PC and GYS2 expression in liver was increased 60 min after lactate administration.

[Conclusion]

Our results indicate that exogenous lactate administration increases GLUT4 and FAT/CD36 expression in the muscle as well as glycogen synthase factors (PC, GYS2) in the liver after 60 min. Therefore, lactate supplementation may increase fat utilization as well as induce positive effects on glycogen synthesis in athletes.

INTRODUCTION

Lactate is widely considered a waste product of anaerobic glycolysis (e.g. resistance training and high intensity exercise), and has been recognized to induce fatigue and muscular acidosis by lowering blood pH1,2. However, based on a recent study, lactate does not elicit dramatic acidosis or drastically alter body pH levels3. Moreover, lactate is not only a precursor molecule for gluconeogenesis but also an efficient source of energy through the Cori cycle and the enzyme lactate dehydrogenase (LDH)4,5. Rather, based on the lactate shuttle theory, lactate transporters such as monocarboxylate transporter families (MCTs) increase the intracellular transport of lactate, thereby contributing to reducing acidosis6. Indeed, MCTs transport lactate produced in glycolytic tissues through the blood stream to oxidative tissues which use lactate as energy source7. Therefore, lactate could be reconsidered as an efficient energy source in the body.
Recent studies have investigated, with a greater understanding, the energy-independent role of lactate. Interestingly, lactate administration affects metabolism-related factors. For example, Cerda-Kohler et al. reported that acute intraperitoneal injection of lactate (3 g/kg) affects the AMPK pathway, including the enzymes acetyl-CoA carboxylase (ACC) and TBC1 domain family member 4 (TBC1D4), which control oxidative metabolism factors in the mouse soleus muscle8. Moreover, phosphorylation of pyruvate dehydrogenase (PDH), which is regulated by 5' AMP-activated protein kinase (AMPK) and involved in the conversion of pyruvate to acetyl-CoA, was decreased after lactate injection into the mouse soleus muscle8. Furthermore, injection of 1 g/kg of sodium lactate increased blood lactate concentration by approximately 20 mM after 5 min, and increased the mRNA expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a master regulator of mitochondrial biogenesis, in the mouse gastrocnemius muscle9. Lastly, Hashimoto et al. reported that long-term administration of a lactate-based supplement paired with exercise on mouse decreased scapular fat mass compared to the sedentary and exercise groups, causing a significant loss in body weight10.
Nevertheless, it is still unclear how lactate affects fat metabolism and glycogen synthesis over time. Therefore, the purpose of the present study was to investigate the effect of lactate administration on fat metabolism and glycogen synthesis factors in a time-specific manner.

METHODS

Animal care

Male 7-week-old Sprague Dawley (SD) rats were obtained from Raon Bio Inc. (Yongin, Korea) and cared for, following the ethical guidelines of the Animal Experiment Research Center of Konkuk University. Rats were fed ad libitum with a standard commercial diet and were housed in standard cages under controlled humidity (50 %) and temperature (23 ± 1 °C) with a 12 h light-dark cycle11. This study was approved by the Konkuk University Institutional Animal Care and Use Committee (No. KU18137).

Study groups and treatments

Rats were randomly assigned to one of four groups: 0 min (control, n = 6), 30 min (n = 6), 60 min (n = 6), and 120 min (n = 6). The group names indicate the time at sacrifice after lactate administration via an oral sonde. All rats were orally administered sodium lactate (2 g/kg) after fasting for 2 h. All groups were euthanized and dissected at each time point. Soleus muscle and liver tissues were obtained and stored at - 80 ℃ until further analysis (Figure 1A).
Figure 1.

A. Experimental design. Rats were administered lactate after 2 hours fasting and sacrificed each time point. 0 min, 30 min, 60 min, and 120 min after lactate administration (2 g/kg) are referred to experimental groups. B-D. Effect of lactate administration on the mRNA expression in skeletal muscle. B. pyruvate dehydrogenase (PDH); C. glucose transporter type 4 (GLUT4); D. cluster of differentiation 36 (FAT/CD36). E-G. Effect of lactate administration on the mRNA expression in liver. E. citrate synthase (CS); F. pyruvate carboxylase (PC); G. glycogen synthase 2 (GYS2). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a mention for the normalization of the target mRNA expression. Significant differences between the groups are indicated alphabet and the values are presented the means ± SE (n = 6).

PAN_2020_v24n2_1_f001.jpg

mRNA expression analysis

mRNA expression was assessed by reverse transcriptase (RT) - PCR analysis. Total RNA from the soleus muscle and liver was extracted using QIAzol lysis reagent (QIAGEN, No.79306) and cDNA was synthesized using the amfiRivert cDNA Synthesis Platinum Master Mix (GenDEPOT, R5600). The RT reaction was performed using the following cycling protocol: annealing for 5 min at 25 °C, extension for 50 min at 42 °C, and RT inactivation for 15 min at 70 °C). To amplify the cDNA, Taq DNA polymerase (GenDEPOT, P0701) and specific primers were used. Cycling conditions were selected based on the primers (pre-denaturation for 2 min at 94 °C, followed by 25 - 40 cycles for 15 s at 94 °C, 30 s at 50 - 70 °C, and 1 min at 72 °C). The primer sequences used are listed in Table 1. mRNA expression was quantified using an ethidium bromide-stained 5% agarose gel.
Table 1.

Primer sequences for RT-PCR.

Gene Sequences
GAPDH F-5’ TGC TGG TGC TGA GTA TGT CG 3’
R-5’ CTG AGT AGG CGC CAA TGA G 3’
PDH F-5’ GCA GCA TTG TGG AAA TTA CCT 3’
R-5’ ACT TCG AAG GGT GGG TCA CT 3’
GLUT4 F-5’ CAG ATC GGC TCT GAA GAT GG 3’
R-5’ CTG AGT AGG CGC CAA TGA G 3’
FAT/CD36 F-5’ GCA ACA ACA AGG CCA GGT AT 3’
R-5’ AAG AGC TAG GCA TGG AA 3’
PC F-5’ ACT TGT ATG AGC GGG ACT GC 3’
R-5’ TGA CCT TGA CGG GGA TTG GA 3’
CS F-5’ CCG TGC TCA TGG ACT TGG GCC TT 3’
R-5’ CCC CTG GCC CAA CGT ACA TGC TC 3’
GYS2 F-5’ TTT CCT GGG AAG TGA CCA AC 3’
R-5’ TTT GCT GCA CAG AGA TAC CG 3’

Sequences for the identifying glyceraldehyde 3-phosphate dehydrogenase (GAPDH), pyruvate dehydrogenase (PDH), glucose transporter type 4 (GLUT4), cluster of differentiation 36 (FAT/CD36), pyruvate carboxylase (PC), citrate synthase (CS), and glycogen synthase 2 (GYS2) mRNA.

Statistical analysis

IBM SPSS statistics 25 software was used to analyze data. Significant differences were determined using a oneway analysis of variance, followed by the least significant difference (LSD). Values of p < 0.05 were considered statistically significant and all results are presented as the mean ± the SE (n = 6).

RESULTS

Muscle mRNA expression

To test whether lactate administration affects metabolism factors, we examined mRNA expression in the soleus muscle. Lactate administration altered PDH expression, but this difference was not statistically significant compared to the 0 min control group (Figure 1B). The role of glucose transporter type 4 (GLUT4) is to regulate whole body glucose homeostasis. GLUT4 expression at 120 min was significantly increased compared with 0 and 30 min (Figure 1C). The cluster of differentiation 36 gene (FAT/CD36), which regulates the uptake of fatty acid into cells, was increased at 120 min compared with 0 and 30 min (Figure 1D).

Liver mRNA expression

We also examined mRNA expression in the liver to further elucidate the effect of lactate administration. We selected citrate synthase (CS) and pyruvate carboxylase (PC) for our analysis, which regulate metabolism by regulating the tricarboxylic acid cycle (TCA cycle). Figure 1E and 1F show that lactate administration significantly increased PC and CS expression at 60 min. The expression of glycogen synthase 2 (GYS2) was analyzed to investigate changes in glycogen synthesis in the liver. Interestingly, the expression of GYS2 was significantly higher at 60 min compared to all other time points (Figure 1G).

DISCUSSION

The purpose of the present study was to investigate the effect of exogenous lactate administration on fat metabolism and glycogen synthesis factors in a time-specific (0, 30, 60, 120 min) manner in the rat skeletal muscle and liver.
PDH is the major enzyme that converts pyruvate to acetyl-CoA, and thus increased expression of PDH indicates enhanced carbohydrate oxidation12. Cerda-Kohler et al.8 reported that treatment with lactate decreased PDH expression in the mouse soleus. However, our results did not show any significant differences in PDH expression at 30, 60 and 120 min after lactate administration in the rat soleus. This difference may be due to different methods of lactate administration. Additionally, we saw an increase in the expression of GLUT4 and FAT/CD36 120 min after lactate administration. Glucose and fatty acids are the undisputable source of energy for the body. GLUT4 and FAT/CD36 are the major glucose and fatty acid transporters, respectively13,14, and it is interesting that acute administration of lactate significantly increased the expression of both genes. In a previous study, Jain et al.15 reported that muscle contraction significantly increased GLUT4 and FAT/CD36 protein levels. Moreover, Leick et al.16 reported that GLUT4 and FAT/CD36 were induced in a phase of recovery after endurance exercise in human skeletal muscle. Furthermore, a previous study showed that exercise training increased GLUT4 and FAT/CD36 while also enhancing the rate of fat oxidation17-20. Therefore, we assumed that oral administration of lactate induced an increase in fat oxidation rate in skeletal muscle.
To explore the effect of lactate administration on the liver, we analyzed select mRNA (CS, PC and GYS2) expression. In the first reaction of the TCA cycle, CS converts acetyl-CoA and oxaloacetate into citrate21. Siu et al.22 reported that CS is often used as a marker of metabolic rate regarding oxidative and respiratory capacity. Furthermore, PC converts pyruvate into oxaloacetate, which fuels the TCA cycle with its intermediates23. Accordingly, our results showed that lactate administration significantly increased CS and PC expression at 60 min, which could imply that lactate treatment enhances oxidative capacity.
In addition, the present study showed that lactate administration significantly increased GYS2 at 60 min compared to 0, 30, 120 min. GYS2 converts glucose into glycogen and is the key enzyme for glycogenesis in the liver24. Wilamowitz-Moellendorff et al.25 reported that GYS- knockout mice have a significantly decreased glycogen concentration in liver. Pursell et al.26 showed that inhibition of GYS2 expression restrained glycogen accumulation in the mouse liver. Therefore, lactate administration may enhance glycogen synthesis in the liver.
A limitation of this study is that we did not treat the rats with other doses of lactate or confirmed the effectiveness of an acute treatment. In addition, only mRNA levels and blood analysis were performed. Therefore, in future studies, glycogen concentrations in the muscle and liver should be assessed and the expression of more markers of glucose and fat metabolism should be quantified.
Nevertheless, we confirmed an increased expression of metabolic and glycogen synthesis enzymes such as CS and PC at 60 min after lactate administration. Moreover, a single bout of lactate administration enhanced the expression of GLUT4 and FAT/CD36 at 120 min after treatment. Lastly, the expression of GYS2 was increased, which could result in glycogen accumulation in the liver. In conclusion, we suggest that lactate supplementation may increase fat utilization as well as have positive effects of glycogen synthesis. Further studies are needed to clarify the long-term effects of lactate on exercise capacity in athletes.

Acknowledgments

This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2019S1A5B8099542).

References

1. Hollidge-Horvat MG, Parolin ML, Wong D, Jones NL, Heigenhauser GJF. Effect of induced metabolic alkalosis on human skeletal muscle metabolism during exercise. Am J Physiol - Endocrinol Metab. 2000;278:E316-29. . PMID: 10.1152/ajpendo.2000.278.2.E316.

2. Sutton JR, Jones NL, Toews CJ. Effect of pH on muscle glycolysis during exercise. Clin Sci. 1981;61:331-8. . PMID: 10.1042/cs0610331.

3. Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol. 2004;287:R502-16. . PMID: 10.1152/ajpregu.00114.2004.

4. Brooks GA. Cell-cell and intracellular lactate shuttles. J Physiol. 2009;587:5591-600. . PMID: 10.1113/jphysiol.2009.178350.

5. Stevenson RW, Mitchell DR, Hendrick GK, Rainey R, Cherrington AD, Frizzell RT. Lactate as substrate for glycogen resynthesis after exercise. J Appl Physiol. 1987;62:2237-40. . PMID: 10.1152/jappl.1987.62.6.2237.

6. Brooks GA. The Science and Translation of Lactate Shuttle Theory. Cell Metab. 2018;27:757-85. . PMID: 10.1016/j.cmet.2018.03.008.

7. Brooks GA. The lactate shuttle during exercise and recovery. Med Sci Sports Exerc. 1986;18:360-8. . PMID: 10.1249/00005768-198606000-00019.

8. Cerda-Kohler H, Henríquez-Olguín C, Casas M, Jensen TE, Llanos P, Jaimovich E. Lactate administration activates the ERK1/2, mTORC1, and AMPK pathways differentially according to skeletal muscle type in mouse. Physiol Rep. 2018;6:1-9. . PMID: 10.14814/phy2.13800.

9. Kitaoka Y, Takeda K, Tamura Y, Hatta H. Lactate administration increases mRNA expression of PGC-1α and UCP3 in mouse skeletal muscle. NRC Research Press. 2016;41:695-8. . PMID: 10.1139/apnm-2016-0016.

10. Hashimoto T, Yokokawa T, Narusawa R, Okada Y, Kawaguchi R, Higashida K. A lactate-based compound containing caffeine in addition to voluntary running exercise decreases subcutaneous fat mass and improves glucose metabolism in obese rats. J Funct Foods. 2019;56:84-91. . PMID: 10.1016/j.jff.2019.03.007.

11. Kim J, Hwang H, Park J, Yun HY, Suh H, Lim K. Silk peptide treatment can improve the exercise performance of mice. J Int Soc Sports Nutr. 2014;11:35. . PMID: 10.1186/1550-2783-11-35.

12. Spriet LL, Heigenhauser GJF. Regulation of pyruvate dehydrogenase (PDH) activity in human skeletal muscle during exercise. Exerc Sport Sci Rev. 2002;30:91-5. . PMID: 10.1097/00003677-200204000-00009.

13. Glatz JFC, Luiken JJFP, Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: Implications for metabolic disease. Physiol Rev. 2010;90:367-417. . PMID: 10.1152/physrev.00003.2009.

14. Klip A. The many ways to regulate glucose transporter 4. Appl Physiol Nutr Metab. 2009;34:481-7. . PMID: 10.1139/H09-047.

15. Jain SS, Luiken JJFP, Snook LA, Han XX, Holloway GP, Glatz JFC, & Bonen A. Fatty acid transport and transporters in muscle are critically regulated by Akt2. FEBS Lett. 2015;589:2769-75. . PMID: 10.1016/j.febslet.2015.08.010.

16. Leick L, Plomgaard P, Grønløkke L, Al-Abaiji F, Wojtaszewski JFP, Pilegaard H. Endurance exercise induces mRNA expression of oxidative enzymes in human skeletal muscle late in recovery. Scand J Med Sci Sport. 2010;20:593-9. . PMID: 10.1111/j.1600-0838.2009.00988.x.

17. Talanian JL, Holloway GP, Snook LA, Heigenhauser GJF, Bonen A, Spriet LL. Exercise training increases sarcolemmal and mitochondrial fatty acid transport proteins in human skeletal muscle. Am J Physiol - Endocrinol Metab. 2010;299:180-8. . PMID: 10.1152/ajpendo.00073.2010.

18. Kim J, Park J, Lim K. Nutrition Supplements to Stimulate Lipolysis: A Review in Relation to Endurance Exercise Capacity. J Nutr Sci Vitaminol. 2016;62:141-61. . PMID: 10.3177/jnsv.62.141.

19. Kim J, Lim K. Relationship between FAT/CD36 protein in skeletal muscle and whole-body fat oxidation in endurance-trained mice. J Exerc Nutrition Biochem. 2016; 20:48-52. . PMID: 10.20463/jenb.2016.0057.

20. Kim J, Park J, Kim N, Park HY, Lim K. Inhibition of androgen receptor can decrease fat metabolism by decreasing carnitine palmitoyltransferase I levels in skeletal muscles of trained mice. Nutr Metab. 2019;27:82-91. . PMID: 10.1186/s12986-019-0406-z.

21. Owen OE, Kalhan SC, Hanson RW. The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem. 2002;277:30409-12. . PMID: 10.1074/jbc.R200006200.

22. Siu PM, Donley DA, Bryner RW, Alway SE. Citrate synthase expression and enzyme activity after endurance training in cardiac and skeletal muscles. J Appl Physiol. 2003;94:555-60. . PMID: 10.1152/japplphysiol.00821.2002.

23. Merritt ME, Harrison C, Sherry AD, Malloy CR, Burgess SC. Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13C magnetic resonance. Proc Natl Acad Sci U S A. 2011;108:19084-9. . PMID: 10.1073/pnas.1111247108.

24. Nuttall FQ, Gilboe DP, Gannon MC, Niewoehner CB, Tan AWH. Regulation of glycogen synthesis in the liver. Am J Med. 1988;85:77-85. . PMID: 10.1016/0002-9343(88)90400-7.

25. von Wilamowitz-Moellendorff A von, Hunter RW, García-Rocha M, Kang L, López-Soldado I, Lantier L, Patel K, Peggie MW, Martínez-Pons C, Voss M, Calbó J, Cohen PTW, Wasserman DH, Guinovart JJ, Sakamoto K. Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis. Diabetes. 2013;62:4070-82. . PMID: 10.2337/db13-0880.

26. Pursell N, Gierut J, Zhou W, Dills M, Diwanji R, Gjorgjieva M, Saxena U, Yang JS, Shah A, Venkat N, Storr R, Kim B, Wang W, Abrams M, Raffin M, Mithieux G, Rajas F, Dudek H, Brown BD, Lai C. Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases. Mol Ther. 2018;26:1771-82. . PMID: 10.1016/j.ymthe.2018.04.023.



ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
Korea University, 145 Anam-Ro, Seongbuk-gu,Seoul 02841, Republic of Korea
Tel: +82-10-2235-0018    Fax: +82-2-3290-2315    E-mail: jenbedit@gmail.com                

Copyright © 2024 by Korean Society for Exercise Nutrition.

Developed in M2PI

Close layer
prev next